Abstract:Systemic lupus erythematosus (SLE) is a common autoimmune disease with a complex genetic etiology. In the last 2 years, exciting insights supporting the notion that the interleukin17 (IL-17)–producing Th 17 cell subset exerts proinflammatory activity in the pathogenesis of several autoimmune or allergic diseases, including asthma, atopic dermatitis, rheumatoid arthritis (RA), and SLE, have emerged (1,2). High production of IL-17 is observed in SLE patients, and several compounds targeting IL-17 have demonstrated marked clinical efficacy (1,2). Genetic studies have reproducibly demonstrated an association between susceptibility to RA and polymorphisms of the CCR6 gene, a surface marker for Th17 cells (3,4). However, to date no direct link between CCR6 and SLE has been found from genetic studies, although higher percentages of CCR61 T helper cells were observed in patients with SLE, and especially in those with lupus nephritis (LN), compared to controls (5,6). The current study was undertaken to investigate whether there are any associations between CCR6 polymorphisms and susceptibility to LN. The discovery cohort in this study comprised 500 LN patients (mean 6 SD age 32.0 6 11.5 years; 83.6% female) and 900 unrelated healthy individuals (age 31.5 6 8.4 years; 40.1% female). The replication cohort consisted of 626 LN patients (age 32.5 6 12.8 years; 84.0% female) and 1,932 healthy individuals (age 40.9 6 12.7 years; 47.7% female), as well as 1,063 SLE patients without evidence of renal involvement (age 36.6 6 13.4 years; 90.5% female) as an additional control group. All of the SLE patients met the American College of Rheumatology revised criteria for the disease (7). The study was approved by the medical ethics committee of Peking University, and all subjects provided informed consent. Two intronic single-nucleotide polymorphisms (SNPs), rs3093023 and rs3093024, known to be associated with RA with high association signals (3,4), were selected for study, and genotyping was conducted by TaqMan allele discrimination assay (Applied Biosystems) as previously described (8,9). Direct sequencing was performed in 45 samples that were randomly selected on the basis of rs3093024 genotype (15 subjects with the A/A genotype, 15 with the G/A genotype, and 15 with the G/G genotype) to determine whether rs3093024 could tag the recently identified functional CCR6DNP (a triallelic dinucleotide polymorphism of CCR6) (3). The power of the study was calculated using CaTS (http://www.sph.umich.edu/csg/abecasis/CaTS/). As rs3093023 and rs3093024 are in high linkage disequilibrium (LD) (r 5 0.98), indicating that statistical tests performed on each SNP are highly dependent, no multiple correction was applied. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Statistical analyses were performed with SPSS16.0 software. Functional annotations of variants were obtained from the HaploReg and regulomeDB databases. A total of 5,021 Chinese subjects were included as described above. The call rates for rs3093024 and rs3093023 were 99.82% and 98.94%, respectively. Both SNPs studied were in Hardy-Weinberg equilibrium in patients and controls (P . 0.05). With the expected frequency of the rs3093024 and rs3093023 minor allele (40%), the study had a power of 96– 99% to detect a 1.20-fold increased risk in the discovery and replication cohorts separately and combined. The frequency of the A allele of rs3093024 was significantly higher in patients with LN as compared to healthy controls both in the discovery cohort and in the replication cohort (P 5 1.32 3 10 and P 5 4.15 3 10, respectively) (Table 1).

Investigation of C1-complex Regions Reveals New C1Q Variants Associated with Protection from Systemic Lupus Erythematosus, and Affect Its Transcript Abundance

Association of Variants in CCR6 with Susceptibility to Lupus Nephritis in Chinese

Association Between C1q, TRAIL, and Tim-1 Gene Polymorphisms and Systemic Lupus Erythematosus

The ZNF76 rs10947540 polymorphism associated with systemic lupus erythematosus risk in Chinese populations

A Single-Nucleotide Polymorphism Rs4639966 in 11q23.3 is Associated with Clinical Features of Systemic Lupus Erythematosus in the Chinese Population.

Relationship between CD274 gene polymorphism and systemic lupus erythematosus risk in a Chinese Han population

A Novel Single-Nucleotide Polymorphism Of The Fc Gamma Receptor Iiia Gene Is Associated With Genetic Susceptibility To Systemic Lupus Erythematosus In Chinese Populations: A Family-Based Association Study

3 Confirmation of 5 novel susceptibility loci for systemic lupus erythematosus (sle) and integrated network analysis of 82 sle susceptibility loci

Genetic susceptibility and clinical features of CYP2D6 associated with systemic lupus erythematosus in a Chinese population

Several Critical Cell Types, Tissues, and Pathways Are Implicated in Genome-Wide Association Studies for Systemic Lupus Erythematosus

Association of a Common Complement Receptor 2 Haplotype with Increased Risk of Systemic Lupus Erythematosus

A Rare Variant (rs933717) at FBXO31‐MAP1LC3B in Chinese is Associated with Systemic Lupus Erythematosus

Lupus susceptibility region containing CTLA4 rs17268364 functionally reduces CTLA4 expression by binding EWSR1 and correlates IFN-α signature

Preferential Association of a Functional Variant in Complement Receptor 2 with Antibodies to Double-Stranded DNA

Association of DYNC1H1 gene SNP/CNV with disease susceptibility, GCs efficacy, HRQOL, anxiety, and depression in Chinese SLE patients

Single-Nucleotide Polymorphisms and Haplotype of Cyp2e1 Gene Associated with Systemic Lupus Erythematosus in Chinese Population

Contribution of dendritic cell immunoreceptor (DCIR) polymorphisms in susceptibility of systemic lupus erythematosus and primary Sjogren’s syndrome

SCUBE3 Is Likely a Susceptibility Gene for Systemic Lupus Erythematosus for Chinese Populations

Association between complement 4 copy number variation and systemic lupus erythematosus: a meta-analysis

Association of chemokine CXCL12-3'G801A polymorphism with systemic lupus erythematosus in a Han Chinese population.

Confirmation of Five Novel Susceptibility Loci for Systemic Lupus Erythematosus (SLE) and Integrated Network Analysis of 82 SLE Susceptibility Loci